Argenx Wins FDA Nod Expanding VYVGART Label To All Adult GMG Patients

AI Briefing

• – FDA approves label expansion for Argenx's VYVGART for adult GMG patients
• – VYVGART now available for all adult patients with generalized myasthenia gravis
• – Argenx's treatment aims to improve symptoms and quality of life for GMG patients